1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid


Chemical Name: 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid
CAS Number: 97867-33-9
Product Number: AG005XD3(AGN-PC-0JMWSN)
Synonyms:
MDL No:
Molecular Formula: C20H24FN3O6
Molecular Weight: 421.4195

Identification/Properties


Properties
MP:
255-257°C
BP:
581.8°C at 760 mmHg
Storage:
Inert atmosphere;Room Temperature;
Form:
Solid
Computed Properties
Molecular Weight:
421.425g/mol
Hydrogen Bond Donor Count:
4
Hydrogen Bond Acceptor Count:
10
Rotatable Bond Count:
4
Exact Mass:
421.165g/mol
Monoisotopic Mass:
421.165g/mol
Topological Polar Surface Area:
130A^2
Heavy Atom Count:
30
Formal Charge:
0
Complexity:
631
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
2
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
Signal Word:
Warning
UN#:
-
Hazard Statements:
H302-H315-H319-H335
Precautionary Statements:
P261-P305+P351+P338
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



The compound 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid in combination with 2-hydroxypropanoic acid (1:1) plays a crucial role in chemical synthesis, particularly in the development of novel pharmaceuticals. This unique combination synergistically enhances the reactivity and selectivity of reactions, leading to the formation of complex molecular structures with potential therapeutic applications. The functional groups present in both compounds enable precise control over the formation of key intermediates, facilitating the synthesis of bioactive molecules with enhanced pharmacological properties. Its application in chemical synthesis opens up opportunities for the creation of innovative drug candidates with improved efficacy and reduced side effects.